-
-
-
Loading
Loading
The files shed light on a controversial area of medicine that has largely retreated into the shadows
Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?
People are seeing extreme weather in action, but not voting to stop it
Sanity, at least, is no longer a formal requirement. But watch out for the letterboxes